Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

De Novo Cerebral Microembolization Associated With Patent Foramen Ovale Closure

NCT06347276 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT06347276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06347276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
De Novo Cerebral Microembolization Associated With Patent Foramen Ovale Closure
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2024
Completion date
December 31, 2026
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial septal defect, patent foramen ovale (pfo), thrombosis cardiac